Akèy › Kansè pwostat rezistan a kastasyon › Kalifòni › Los Angeles
Etid klinik pou Kansè pwostat rezistan a kastasyon nan Los Angeles, CA
8 etid pou Kansè pwostat rezistan a kastasyon ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Ap rekriteFaz 3
- Cedars Sinai Medical Center, Los Angeles
- Ronald Reagan UCLA Medical Center, Los Angeles
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Ap rekriteFaz 3
- USC Norris Comprehensive Cancer Center, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
- Ronald Reagan UCLA Medical Center, Los Angeles
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Ap rekriteFaz 1
- START Los Angeles, Los Angeles
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
Ap rekriteFaz 1/2
- UCLA Hematology/Oncology - Santa Monica ( Site 0044), Los Angeles
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Ap rekriteFaz 1/2
- UCLA Hematology & Oncology ( Site 0003), Los Angeles
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Ap rekriteFaz 1
- USC Norris Comprehensive Cancer Center, Los Angeles
- UCLA Department of Medicine, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- The Angeles Clinic and Research Institute, Los Angeles
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
Ap rekriteFaz 4
- VA Greater Los Angeles Healthcare System, Los Angeles
Etid Kansè pwostat rezistan a kastasyon nan lòt vil
- New York City, NY7 etid
- Seattle, WA6 etid
- Houston, TX6 etid
- Boston, MA5 etid
- Queens, NY4 etid
- Philadelphia, PA4 etid
- Pittsburgh, PA4 etid
- Mountain View, CA3 etid
- Myrtle Beach, SC3 etid
- Cincinnati, OH3 etid
- Nashville, TN3 etid
- Dallas, TX3 etid
Lòt etid nan Los Angeles
- Kansè Poumon ki pa ti selil87 etid
- Kansè (tout kalite)74 etid
- Kansè nan tete73 etid
- Kansè pwostat61 etid
- Kansè kolorektal59 etid
- Kansè Metastatik57 etid
- Kansè ovè50 etid
- Kansè poumon45 etid
- Karsinòm selil skuamèz tèt ak kou42 etid
- Kansè pankreyas35 etid
- Kansè Endomèt34 etid
- Melanom34 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.